GENE ONLINE|News &
Opinion
Blog

Incyte Corporation
Incyte’s Zynyz Secures FDA Approval for Treating a Rare and Aggressive Skin Cancer
2023-03-23
Incyte’s Rare Cancer Drug Snags Second FDA Approval
2022-08-29
Syndax, Incyte Sign $602 Million Collab to Advance Monoclonal Antibody
2021-09-29
FDA Approves Incyte’s Jakafi for Chronic Graft-Versus-Host Disease
2021-09-23
China’s InnoCare, Incyte Enter Collaboration And License Deal for Monoclonal Antibody in Greater China
2021-08-18
Another Checkpoint Inhibitor Set to Make Market Appearance as FDA Grants Priority Review
2021-01-25
Novartis Announces Failure of Ruxolitinib Trial in Severe COVID-19
2020-12-18
ASH2020: Incyte Presents Positive Phase 3 Data for cGVHD Drug, Ruxolitinib
2020-12-06
Lilly, Incyte Gaining Ground in the Fight against Alopecia Areata
2020-11-01
Eli Lilly Gets FDA Breakthrough Status for Alopecia Drug
2020-03-17
LATEST
NVIDIA’s Global AI Strategy: A Multi-Region Push with Taiwan and Middle East as Key Hubs
2025-05-22
MIRDC Establishes CDMO Innovation Center in Boston to Advance into Innovative Healthcare
2025-05-22
A Look at Taiwan-German Collaborative Solutions in Precision Medicine, Drug Development, and Medical Tech
2025-05-21
ACOG Updates Pain Management Guidelines for IUD Insertions as Novavax Vaccine Gains Approval
2025-05-20
NIH Restores Research Funding to Previously Defunded Scientists Amid Policy Shifts
2025-05-20
Prime Medicine Reduces Workforce by 25 Percent and Appoints David Schenkein as New CEO
2025-05-20
UnitedHealth Group Stock Drops Amid Rising Medicare Advantage Costs and Regulatory Debates
2025-05-20
EVENT
2025-05-30
ASCO Annual Meeting 2025
Chicago, U.S.A
2025-06-11
ISSCR 2025 Annual Meeting
Hong Kong
2025-06-16
US BIO International Convention
Boston, U.S.A.
Scroll to Top